StockDuty ← Dashboard Oct 02, 2026 06:28 PM ET
SignalCorporate

CRISPR Therapeutics to Present Clinical Data on Zugocabtagene Geleucel (Zugo-cel) in Autoimmune Disease at the American College of Rheumatology (ACR) Convergence 2026

CRISPR Therapeutics will present clinical data on Zugo-cel in autoimmune disease at ACR Convergence 2026.

What changed
CRISPR Therapeutics will present clinical data on Zugo-cel in autoimmune disease at ACR Convergence 2026.
Why it matters
CRISPR Therapeutics will present clinical data on Zugo-cel in autoimmune disease at ACR Convergence 2026. — impact context not separately stored; see What changed.
Sources
eodhd
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →